 1 Agents affecting nervous system and sensory organs
|
 11 Agents affecting central nervous system
|
12 Agents affecting peripheral nervous system
|
121 Local anesthetics
|
122 Skeletal muscle relaxants
|
 1221 Mephenesins
|
1222 Chlorzoxazons
|
1223 Synthetic curares
|
1224 Cholines
|
D02275 Suxamethonium chloride hydrate (JP19)
|
1225 Carbamates
|
D00402 Methocarbamol (JAN/USP/INN)
D00770 Chlorphenesin carbamate (JP19/USAN)
|
1226 Alkaloids
|
1229 Others
|
D00765 Rocuronium bromide (JAN/USP/INN)
D00783 Botulinum toxin type A (JAN)
D10012 Incobotulinumtoxin A (JAN/USAN)
D02064 Pridinol mesilate (JAN)
D02274 Dantrolene sodium (USP); Dantrolene sodium hydrate (JP19)
|
123 Autonomic nervous system agents
|
124 Antispasmodics
|
125 Diaphoretics, anhidrotics
|
129 Miscellaneous
|
13 Agents affecting sensory organs
|
19 Other agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
|
3 Agents affecting metabolism
|
31 Vitamins
|
32 Nutrients, tonics
|
33 Blood and body fluid agents
|
331 Blood substitutes
|
332 Hemostatics
|
333 Anticoagulants
|
339 Miscellaneous
|
3391 Protamines
|
3399 Others
|
D00109 Aspirin (JP19/USP); Aspalon (JAN)
D00769 Clopidogrel bisulfate (USP); Clopidogrel sulfate (JP19); Clopidogrel sulfate tablets (JP19)
D01028 Ticlopidine hydrochloride (JP19/USP)
D01551 Beraprost sodium (JP19/USAN)
D05597 Prasugrel hydrochloride (JAN/USAN)
D01896 Cilostazol (JP19/USP/INN)
D09017 Ticagrelor (JAN/USAN/INN)
D10513 Clopidogrel sulfate and aspirin
D10527 Acetylsalicylic acid and lansoprazole
D12835 Apadamtase alfa and cinaxadamtase alfa
D11160 Caplacizumab (USAN/INN); Caplacizumab (genetical recombination) (JAN)
D10476 Lusutrombopag (JAN/USAN/INN)
D10307 Avatrombopag maleate (JAN/USAN)
D11701 Luspatercept (USAN/INN); Luspatercept (genetical recombination) (JAN)
D03235 Filgrastim (USP/INN); Filgrastim (genetical recombination) (JP19); Filgrastim (genetical recombination) [Filgrastim biosimilar 1] (JAN); Filgrastim (genetical recombination) [Filgrastim biosimilar 2] (JAN); Filgrastim (genetical recombination) [Filgrastim biosimilar 3] (JAN)
D03247 Lenograstim (USAN/INN); Lenograstim (genetical recombination) (JP19)
D06889 Pegfilgrastim (USAN/INN); Pegfilgrastim (genetical recombination) (JAN); Pegfilgrastim (genetical recombination) [Pegfilgrastim biosimilar 1] (JAN); Pegfilgrastim (genetical recombination) [Pegfilgrastim biosimilar 2] (JAN)
D08971 Plerixafor (JAN/USAN/INN)
D03960 Aspirin and dialuminate
D10741 Idarucizumab (USAN/INN); Idarucizumab (genetical recombination) (JAN)
D11029 Andexanet alfa (USAN/INN); Andexanet alfa (genetical recombination) (JAN)
D01624 Sarpogrelate hydrochloride (JP19)
D01892 Icosapent ethyl (USAN); Ethyl icosapentate (JP19)
D04981 Tromethamol, sodium chloride and potassium chloride
D08746 Hot water extract of Mycobacterium tuberculosis
D11804 Aspirin and vonoprazan
|
34 Dialysis agents
|
39 Other agents affecting metabolism
|
391 Liver disease agents
|
392 Antidotes
|
393 Habitual intoxication agents
|
394 Gout preparations
|
395 Enzyme preparations
|
396 Antidiabetic agents
|
3961 Sulfonylureas
|
3962 Biguanides
|
3969 Others
|
D11034 Insulin glargine and lixisenatide
D11567 Insulin degludec and liraglutide
D13245 Insulin icodec (genetical recombination) and semaglutide (genetical recombination)
D09744 Pioglitazone hydrochloride and metformin hydrochloride (JP19)
D09848 Pioglitazone hydrochloride and glimepiride tablets (JP19)
D10743 Vildagliptin and metformin hydrochloride
D10159 Alogliptin benzoate and pioglitazone hydrochloride
D10253 Alogliptin benzoate and metformin hydrochloride
D10588 Empagliflozin and linagliptin
D00216 Acarbose (JAN/USAN/INN)
D00625 Miglitol (JP19/USAN/INN)
D01665 Voglibose (JP19/USAN/INN)
D00945 Pioglitazone hydrochloride (JP19/USP)
D06645 Sitagliptin phosphate (USAN); Sitagliptin phosphate hydrate (JP19)
D07080 Vildagliptin (JAN/USAN/INN)
D09753 Saxagliptin hydrate (JAN)
D06553 Alogliptin benzoate (JAN/USAN)
D09566 Linagliptin (JAN/USAN/INN)
D09756 Teneligliptin hydrobromide hydrate (JAN)
D08897 Dapagliflozin (JAN/USAN/INN)
D09763 Dapagliflozin propanediol (USAN); Dapagliflozin propylene glycolate hydrate (JP19)
D09592 Canagliflozin (USAN/INN); Canagliflozin hydrate (JAN)
D10459 Empagliflozin (JAN/USAN/INN)
D10200 Ipragliflozin L-proline (JAN)
D10195 Luseogliflozin hydrate (JAN)
D00594 Repaglinide (JAN/USP/INN)
D01111 Nateglinide (JP19/USP/INN)
D01854 Mitiglinide calcium hydrate (JP19)
D11807 Imeglimin hydrochloride (JAN)
D09780 Anagliptin (JAN/INN)
D09978 Tofogliflozin (USAN); Tofogliflozin hydrate (JAN)
D10160 Mitiglinide calcium hydrate and voglibose
D10179 Trelagliptin succinate (JAN/USAN)
D10317 Omarigliptin (JAN/USAN/INN)
D10897 Teneligliptin and canagliflozin
D11064 Sitagliptin and ipragliflozin
D11109 Anagliptin and Metformin hydrochloride
|
397 Metabolic disease preparations & combinations
|
399 Miscellaneous
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
71 Dispensing medicines
|
72 Intracorporeal diagnostic agents
|
73 Public health agents
|
74 Extracorporeal diagnostic agents
|
741 General testing reagents
|
742 Blood testing reagents
|
743 Biochemical testing reagents
|
744 Serum-immunological testing reagents
|
745 Bacteriological testing reagents
|
7451 Culture media
7452 Media for confirmation of general properties
7453 Test media for each bacteria genus
7454 Test media for enterobacteria and related bacteria
7455 Test media for pathogenic vibrio
7456 Test media for pleuropneumonia-like organism (PPLO)
7457 Disks
7458 Test media for urinary tract infection
7459 Others
|
746 Patho-tissue testing reagents
|
747 Radioactive medicines
|
749 Miscellaneous
|
79 Other agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan